Stock on move June 16th 2008

Monolithic Power System(MPWR) Semiconductor Play ,company delivers chips that are very smaller and more integrated than a lot of other players in the huge analog chip industry.Its ability to rollout new products destined for the consumer electronics, computing and industrial markets.
Its core business, cold cathode fluorescent lighting, has fueled growth in recent years. Those products are used to light up screens in notebook PCs, TVs and other monitors. But now, more growth is coming from DC-DC chips - which convert direct current from one voltage level to another - especially higher-voltage and higher-current ones that broaden its addressable market.
Monolithic is gaining market share due in large part to its ability to design parts than can carry and handle higher power,company gets its chip manufactured in low-cost plants in China,so Monolithic competes well on price, too. Analyst expect 2008 earnings to rise by about 35% over last year, to $1.00 a share.

Buy point 26.26
Target 31.50
Stop loss: 22.70


Olin Corp (OLN) Chemical and Copper Play,company largest revenue business is its brass division, which makes roll copper sheet and strips, pipes and tubes for electronics, automotive and household goods. Olin other division is chemical division producing chlor-alkali-based chemical ingredients.

Olin's chemical operations are divided among plants in New York, Georgia, Alabama, Tennessee and Brazil. The plants process plain old salt into chlor-alkali, then reduce that into chlorine, caustic soda and various acids and chemicals. Manufacturers and commercial customers stir the chemicals into scads of industrial recipes.

Chlorine and Caustic Soda prices are going up and also higher copper prices are going to stay here for a while.Company is going to acheive good growth for some more quaters unless and untill slowdown in economy and material cost affecting its growth.

Buy point 24.63
Target 29.50
Stop loss: 21.75

Eresearch Technology(ERES) The Philadelphia-based firm offers cardiac clinical trial management software. Pharmaceutical companies and clinical research labs use it for trial data collection, interpretation and distribution.Comapny's see saw growth decline has finally saw some good quaterly growth numbers it picked up to 100%, 17%, 120% and 120% growth the past four quarters. Revenue grew 8%, 8%, 45% and 60% during those periods.


Buy point 16.80
Target 19.60
Stop loss: 14.00


India Stocks:

Pfizer is holding talks with India's pharmaceutical major Ranbaxy in 4.6Billion$ deal.Look for other Indian companies like Dr.Reddy(RDY) and Cipla to be in play.